a
Select Page

Portfolio

We partner with companies with diversified programs across various therapeutic areas and development stages.

Intercept

Bile Acids Therapeutics for Liver Diseases

Innovheart

Transcatether Mitral Valve Replacement

Congenia

Mitochondrial mPTP Platform

Intercept

Nanotechnology Based Liquid Biopsy Platform

EryDel

Erythrocyte Mediated Therapies for Rare Diseases

EryDel

Therapies for Chronic Urological Diseases

Intercept

Targeted Immunotherapy for Solid Tumors